Table 1.
Baseline characteristics of 106 932 men diagnosed with prostate cancer in 2006–2016 in PCBaSe 4.0.
Fig 1.
Proportion and number of men with metastases stratified by prostate-specific antigen (PSA) and Gleason Grade Groups (GGG).
Fig 2.
Fagan’s nomogram for calculation of post-test probabilities of metastatic prostate cancer.
Lines indicate post-test probability of metastatic prostate cancer for men with prostate-specific antigen (PSA) above given cut-off related to the corresponding pre-test probability (prevalence) by T stage and Gleason Grade Group.